{"SPADE_UN_17619": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17619", "Peptide Name": "PMI-HIF1-1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "TSFAEYWALLSXLAXYXP", "Sequence Length": 18, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "MDM2, MDMX", "Linear/Cyclic": "Linear", "N-terminal Modification": "Acetylation", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C85H112N16O20", "Mass": 231132, "PI": 3.85, "Net Charge": -1, "Hydrophobicity": 0.483, "Half Life": "Mammalian:7.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression", "Pubmed ID": "36185610", "Reference": "Theranostics. 2022 Sep 11;12(15)6665-6681.", "Author": "Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=36185610"}], "Frequent Amino Acids": "ALX", "Absent Amino Acids": "CDGHIKMNOQRUV", "Basic Residues": 0, "Acidic Residues": 1, "Hydrophobic Residues": 11, "Polar Residues": 8, "Positive Residues": 0, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11112", "Similarity": 0.8333333333333334, "Sequence": "TSFAEYWNLLSP"}, {"SPADE_ID": "SPADE_N_01789", "Similarity": 0.7142857142857143, "Sequence": "LLSLALAALPKLFCLIFKKC"}, {"SPADE_ID": "SPADE_UN_08764", "Similarity": 0.6666666666666666, "Sequence": "LSLATFAKIFMTRSNWSLKRFNRL"}]}}}